Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.880 +0.090 (+2.37%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist

Price and Volume

Volume	1,867,479
Open	3.820
Bid (Size)	3.880 (18,300)
Ask (Size)	3.890 (3,400)
Prev. Close	3.790
Today's Range	3.782 - 4.015
52wk Range	1.665 - 6.210
Shares Outstanding	112,280,375
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Maravai LifeSciences Announces November 2025 Investor Conference Schedule

November 10, 2025

From Maravai LifeSciences, Inc.

Via Business Wire

Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance ↗

November 06, 2025

Maravai LifeSciences (MRVI) stock fell after Q3 2025 revenue missed estimates. The company reported a net loss and provided full-year guidance below analyst expectations.

Via Chartmill

Performance

YTD	+14.1%	+14.1%
1 Month	+7.5%	+7.5%
3 Month	+24.4%	+24.4%
6 Month	+49.2%	+49.2%
1 Year	-34.8%	-34.8%

More News

Maravai LifeSciences Reports Third Quarter 2025 Financial Results

November 06, 2025

From Maravai LifeSciences Holdings, Inc.

Via Business Wire

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders

October 29, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

What to Expect from Maravai LifeSciences's Earnings ↗

August 08, 2025

Via Benzinga

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025

October 22, 2025

From Maravai LifeSciences, Inc.

Via Business Wire

MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 02, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

September 09, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

August 11, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports

August 11, 2025

Via MarketMinute

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

July 28, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI

July 25, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

July 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

July 14, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

July 08, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI

June 27, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

June 25, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

June 24, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors

June 09, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology

June 03, 2025

From TriLink BioTechnologies

Via Business Wire

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

May 21, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

Maravai LifeSciencesReleases 2024 Sustainability Report

May 21, 2025

From Maravai LifeSciences Holdings LLC

Via GlobeNewswire

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

May 20, 2025

From TriLink BioTechnologies

Via Business Wire

Frequently Asked Questions

Is Maravai LifeSciences Holdings, Inc. - Class A common stock publicly traded?

Yes, Maravai LifeSciences Holdings, Inc. - Class A common stock is publicly traded.

What exchange does Maravai LifeSciences Holdings, Inc. - Class A common stock trade on?

Maravai LifeSciences Holdings, Inc. - Class A common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock?

The ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock is MRVI on the Nasdaq Stock Market

What is the current price of Maravai LifeSciences Holdings, Inc. - Class A common stock?

The current price of Maravai LifeSciences Holdings, Inc. - Class A common stock is 3.880

When was Maravai LifeSciences Holdings, Inc. - Class A common stock last traded?

The last trade of Maravai LifeSciences Holdings, Inc. - Class A common stock was at 01/06/26 04:00 PM ET

What is the market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock?

The market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock is 435.65M

How many shares of Maravai LifeSciences Holdings, Inc. - Class A common stock are outstanding?

Maravai LifeSciences Holdings, Inc. - Class A common stock has 436M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.